AYTU BIOPHARMA, INC (AYTU) › Capital ExpendituresAYTU BIOPHARMA, INC (AYTU) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2014: $9.3K2015: $02016: $252.9K2017: $111.6K2018: $74.7K2019: $59.8K2020: $02024: $329.0K2025: $228.0K$228.0K2014Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$228.0K-30.7%2024$329.0K—2020$0-100.0%2019$59.8K-19.9%2018$74.7K-33.1%2017$111.6K-55.9%2016$252.9K—2015$0-100.0%2014$9.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share